Molecular, Cellular, and Tissue Characterization Unit
Molecular, Cellular, and Tissue Characterization Unit
批准号:
10005916
负责人:
JOE W. GRAY
金额:
$73.38万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-19 至 2023-08-31
关键词:
3-DimensionalATAC-seqAftercareAntibodiesAntigen PresentationArchitectureAtlasesBiopsyCDK4 geneCellsChemicalsChromatinCollectionCost ControlDetectionDisseminated Malignant NeoplasmDrug TargetingEventExtracellular MatrixFaceFluorescenceFluorescence MicroscopyFormalinFreezingGene Expression ProfileGenerationsGenomeGenomic InstabilityGenomicsGoalsHumanImageImage AnalysisImmuneImmune checkpoint inhibitorImmunofluorescence ImmunologicImmunohistochemistryImmunomodulatorsIndividualIonsLabelLesionMalignant NeoplasmsMalignant neoplasm of prostateMapsMechanicsMetastatic breast cancerMolecularMutationOligonucleotidesParaffin EmbeddingPathway interactionsPatientsPeriodicityPharmaceutical PreparationsPlant ResinsPrimary NeoplasmProductionRadiology SpecialtyResistanceResolutionSamplingScanning Electron MicroscopySignal TransductionSpecimenStainsStromal CellsTechnologyTherapeuticTimeTissuesWorkbasecancer cellcastration resistant prostate cancercohortcombinatorialcomparativedrug efficacyepigenomeepigenomicsexhaustionhigh dimensionalityhormone receptor-positivehormone therapyimmune checkpointimprovedindexingindividual patientinhibitor/antagonistinsertion/deletion mutationmalignant breast neoplasmmolecular imagingneoplastic cellnext generationparaformprospectiveresistance mechanismsingle cell sequencingtargeted treatmenttechnology developmenttriple-negative invasive breast carcinomatumortumor-immune system interactions
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT – Characterization Unit
The Characterization Unit will be responsible for omic and multiscale image analyses of pairs of biopsies taken
pre- and on/post treatment from patients with metastatic breast and prostate cancer undergoing treatment with
current generation pathway and immune checkpoint targeted treatments. The paired biopsies represent sensitive
and resistant lesions and comparative analyses of these enable discovery of mechanisms of resistance. Twenty
pairs of samples each from three treatment cohorts will be analyzed. Specifically, (a) hormone-receptor positive
breast cancer (HRBC) undergoing treatment with a CDK4/6 inhibitor in combination with endocrine therapy, (b)
triple negative breast cancer (TNBC) undergoing treatment with a PARP inhibitor and an immunomodulatory
agent, and (c) castration resistant prostate cancer (CRPC) undergoing treatment with enzalutamide. Aim 1 will
analyze OCT frozen biopsies using Topographic Single Cell Sequencing (TSCS) to cells isolated from spatially
defined regions to enable analysis of genomic copy number changes, mutations, and indels and Single-cell
Combinatorial Indexing ATAC-seq (sci-ATAC-seq) to elucidate chromatin accessibility in single cells. The cells
analyzed using sci-ATAC-seq will be computationally mapped to cyclic immunofluorescence (cycIF) stained sec-
tions based on predicted gene expression patterns. Aim 2 will analyze formalin-fixed paraffin embedded (FFPE)
sections using multiplex immunohistochemistry (mIHC) and cycIF to assess the tumor and stromal cell compo-
sition and the molecular states thereof. In addition, next generation cycIF using oligonucleotide labeled antibod-
ies will be developed to enable high dimension cycIF staining and imaging using both conventional and super
resolution fluorescence microscopy. Aim 3 will analyze paraformaldehyde fixed, resin embedded (PFRE) speci-
mens using Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) to identify ultrastructural changes in
2D images and targeted 3D volumes with 4-nm resolution. In addition, work in this aim will assess the utility of
Serial Block Face Imaging SEM (SBFI) to define 3D ultrastructural changes in larger volumes, but at lower res-
olution.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10166784
-
项目类别:
-
资助金额:$22.76万
-
财政年份:2020
-
负责人:JOE W. GRAY
-
依托单位:
Understanding the Impact of Microscale and Nanoscale Heterogeneity and Resistance
-
批准号:10166790
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2020
-
负责人:JOE W. GRAY
-
依托单位:
Imaging Management and Analysis Core
-
批准号:10166786
-
项目类别:
-
资助金额:$20.41万
-
财政年份:2020
-
负责人:JOE W. GRAY
-
依托单位:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
-
批准号:9788351
-
项目类别:
-
资助金额:$175.77万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
-
批准号:10005913
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
-
批准号:10471933
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Molecular, Cellular, and Tissue Characterization Unit
-
批准号:10471935
-
项目类别:
-
资助金额:$75.24万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Molecular, Cellular, and Tissue Characterization Unit
-
批准号:10246896
-
项目类别:
-
资助金额:$74.64万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
-
批准号:10246894
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Omic and Multidimensional Spatial Atlas of Metastatic Breast and Prostate Cancers
-
批准号:10005901
-
项目类别:
-
资助金额:$175.77万
-
财政年份:2018
-
负责人:JOE W. GRAY
-
依托单位:
Nanoparticle-based targeted codelivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer
-
批准号:10086165
-
项目类别:
-
资助金额:$51.34万
-
财政年份:2017
-
负责人:JOE W. GRAY
-
依托单位:
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
-
批准号:8875506
-
项目类别:
-
资助金额:$68.24万
-
财政年份:2015
-
负责人:JOE W. GRAY
-
依托单位:
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
-
批准号:9068051
-
项目类别:
-
资助金额:$67.29万
-
财政年份:2015
-
负责人:JOE W. GRAY
-
依托单位:
Extrinsic Perturbations of Cell Physiology and Associated Regulatory Networks
-
批准号:8925126
-
项目类别:
-
资助金额:$171.46万
-
财政年份:2014
-
负责人:JOE W. GRAY
-
依托单位:
Extrinsic Perturbations of Cell Physiology and Associated Regulatory Networks
-
批准号:9122476
-
项目类别:
-
资助金额:$171.46万
-
财政年份:2014
-
负责人:JOE W. GRAY
-
依托单位:
Extrinsic Perturbations of Cell Physiology and Associated Regulatory Networks
-
批准号:8787861
-
项目类别:
-
资助金额:$171.46万
-
财政年份:2014
-
负责人:JOE W. GRAY
-
依托单位:
Extrinsic Perturbations of Cell Physiology and Associated Regulatory Networks
-
批准号:9319906
-
项目类别:
-
资助金额:$17.5万
-
财政年份:2014
-
负责人:JOE W. GRAY
-
依托单位:
Outreach
-
批准号:8915454
-
项目类别:
-
资助金额:$19.15万
-
财政年份:2014
-
负责人:JOE W. GRAY
-
依托单位:
Developmental Project
-
批准号:8181897
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2010
-
负责人:JOE W. GRAY
-
依托单位:
Administrative Core
-
批准号:8181907
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2010
-
负责人:JOE W. GRAY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:柳静
-
依托单位:
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
-
批准号:62302218
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:张双全
-
依托单位:
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:黄铭坤
-
依托单位:
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
-
批准号:32100438
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:涂晓雨
-
依托单位:
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
-
批准号:82001520
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:汤小晗
-
依托单位:
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
-
批准号:81802809
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:蔡梅春
-
依托单位:
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
-
批准号:31802046
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:张龚炜
-
依托单位:
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
-
批准号:31801915
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2018
-
负责人:茹磊
-
依托单位:
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
-
批准号:31871331
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:张治华
-
依托单位: